(2013)
Secondary genetic lesions in acute myeloid leukemia with inv(16) or t(16;16): a study of the German-Austrian AML Study Group (AMLSG).
Blood 121(1),
170-177.

Marie von Lilienfeld-Toal
National Reference Center for Invasive Fungal Infections Infections in Hematology/Oncology +49 3641 532-1720 marie.lilienfeld-toal@leibniz-hki.deCurriculum vitae
Main Research Areas
- Tumour and infection immunology
- Epidemiology of infections of von Infektionen immunosuppressed patients
- Clinical diagnostic and therapeutical studies
Professional Career
2014 | Deputy head of the Nationales Referenzzentrum für invasive Pilzinfektionen |
2013 | W2-professorship in infection research in haematology and oncology, medical faculty, Friedrich-Schiller University Jena |
2010 | Habilitation in internal medicine, Rheinische Friedrich-Wilhelms University Bonn |
2008-2013 | Senior physician in the dept. haematology / oncology (med. clinic III), University Hospital, Bonn |
2007-2008 | EBMT Fellowship Bone Marrow Transplantation Programme, Leeds, UK |
2007 | Acceptance of the priority area haematology / oncology |
2006 | Specialist in internal diseases |
2003-2004 | Gerok fellowship within the BonFor funding programme, medical faculty Bonn |
1999-2007 | Doctor in practical training (AiP) /assistant physician in internal medicine, University Hospital Bonn |
1999 | PhD in clinical pharmacology, „magna cum laude“, medical faculty, Rheinische Friedrich-Wilhelms University Bonn |
1998 | Staatsexamen (state examination) human medicine |
Awards · Appointments · Scientific Activities
Since 2013 | Member of the ethics commission, medical faculty of the FSU Jena |
Since 2013 | Board member of the working group dealing with infections in haematology and oncology (AGIHO) of the Deutsche Gesellschaft für Hämatologie und internistische Onkologie (DGHO) |
Since 2008 | Member of the AGIHO |
2008-2010 | Assistant lecturer at the medical clinic III of the University Hospital Bonn |
2002-2006 | Member of the statutes commission of the medical faculty of the Rheinische Friedrich-Wilhelms University Bonn |
2009 | Best abstract DGHO |
2008 | Poster award |
Since 2004 | Assessor of several magazines |
Publications
(2012)
Intermediate intensity conditioning regimen containing FLAMSA, treosulfan, cyclophosphamide, and ATG for allogeneic stem cell transplantation in elderly patients with relapsed or high-risk acute myeloid leukemia.
Ann Hematol 91(1),
47-55.
(2012)
Diagnosis of chronic disseminated candidosis from liver biopsies by a novel PCR in patients with haematological malignancies.
Clin Microbiol Infect 18(10),
1010-1016.
(2012)
TET2 mutations in acute myeloid leukemia (AML): results from a comprehensive genetic and clinical analysis of the AML study group.
J Clin Oncol 30(12),
1350-1357.
(2012)
Monosomal karyotype in adult acute myeloid leukemia: prognostic impact and outcome after different treatment strategies.
Blood 119(2),
551-558.
(2012)
TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome.
Blood 119(9),
2114-2121.
(2012)
Novel treatment concepts for graft-versus-host disease.
Blood 119(1),
16-25.
(2011)
Plerixafor with and without chemotherapy in poor mobilizers: results from the German compassionate use program.
Bone Marrow Transplant 46(8),
1045-1052.
(2011)
The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML.
Blood 117(7),
2137-2145.
(2011)
Monitoring of minimal residual disease in NPM1-mutated acute myeloid leukemia: a study from the German-Austrian acute myeloid leukemia study group.
J Clin Oncol 29(19),
2709-2716.